Maximum access to HPV vaccines is crucial

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1564, 2006-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two HPV vaccines get nod in US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 590, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Promoting access to vaccines in the developing world

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 423, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Bivalent vs quadrivalent HPV vaccines: which is best?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 639, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Facilitating Access to Vaccines: An Overview of Legal and Political Issues

By Milstien J.B.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 2, 2003-01 ,pp. : 101-116

Adis International

Access to resources Recommend Favorite

Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1466-1487

Bentham Science Publishers

Access to resources Recommend Favorite